Fanggui Xu

Sir Run Run Hospital
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

STK39 promotes the evolution cascade of hepatocellular carcinoma by facilitating PKR/NF-κB-mediated macrophage inflammatory response.

STK39 promotes the evolution cascade of hepatocellular carcinoma by facilitating PKR/NF-κB-mediated macrophage inflammatory response.

Journal: Oncogene

Published: January 06, 2026

The integration of single-cell and metabolomics reveals the increase of oxidative phosphorylation during the liver metastasis of colorectal cancer.

The integration of single-cell and metabolomics reveals the increase of oxidative phosphorylation during the liver metastasis of colorectal cancer.

Journal: Cancer & metabolism

Published: April 12, 2025

Anti-transcription intermediary factor 1 gamma (TIF1-γ) antibody-positive dermatomyositis associated with adenocarcinoma of the ileocecal region: A first case report.

Anti-transcription intermediary factor 1 gamma (TIF1-γ) antibody-positive dermatomyositis associated with adenocarcinoma of the ileocecal region: A first case report.

Journal: Asian journal of surgery

Published: October 09, 2024

Retraction Note: LncRNA LINC00520 aggravates cell proliferation and migration in lung adenocarcinoma via a positive feedback loop.

Retraction Note: LncRNA LINC00520 aggravates cell proliferation and migration in lung adenocarcinoma via a positive feedback loop.

Journal: BMC pulmonary medicine

Published: July 16, 2024

HBV Infection-Related PDZK1 Plays an Oncogenic Role by Regulating the PI3K-Akt Pathway and Fatty Acid Metabolism and Enhances Immunosuppression.

HBV Infection-Related PDZK1 Plays an Oncogenic Role by Regulating the PI3K-Akt Pathway and Fatty Acid Metabolism and Enhances Immunosuppression.

Journal: Journal of immunology research

Published: March 16, 2022

Inducing Synergistic DNA Damage by TRIP13 and PARP1 Inhibitors Provides a Potential Treatment for Hepatocellular Carcinoma.

Inducing Synergistic DNA Damage by TRIP13 and PARP1 Inhibitors Provides a Potential Treatment for Hepatocellular Carcinoma.

Journal: Journal of Cancer

Published: August 12, 2021

LncRNA LINC00520 aggravates cell proliferation and migration in lung adenocarcinoma via a positive feedback loop.

LncRNA LINC00520 aggravates cell proliferation and migration in lung adenocarcinoma via a positive feedback loop.

Journal: BMC pulmonary medicine

Published: February 09, 2021

Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways.

Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways.

Journal: Cancer gene therapy

Published: November 07, 2020

Down-regulation of miRNA-196b expression inhibits the proliferation, migration and invasiveness of HepG2 cells while promoting their apoptosis via the PI3K/Akt signaling pathway.

Down-regulation of miRNA-196b expression inhibits the proliferation, migration and invasiveness of HepG2 cells while promoting their apoptosis via the PI3K/Akt signaling pathway.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)

Published: September 11, 2019

MicroRNA-101-3p regulates gastric cancer cell proliferation, invasion and apoptosis by targeting PIM 1 expression.

MicroRNA-101-3p regulates gastric cancer cell proliferation, invasion and apoptosis by targeting PIM 1 expression.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)

Published: July 03, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026